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Abstract
Previous immunocytochemical studies have shown that protein kinase CK2 is mostly detected both in the cytoplasm and
the nucleus of most cells. In the present study, CK2 was detected in highly purified plasma membrane preparations from rat
liver. The protein kinase could be released from the membranes by high salt extraction (s 1 M NaCl). Plasma membranes
prepared from SF9 insect cells expressing the K- and L-subunits of CK2 also contained a significant amount of oligomeric
CK2. Furthermore, it was demonstrated in this cell system as well as in rat liver plasma membranes, that the L-subunit of the
kinase is the targeting subunit which mediates the tight association of the enzyme to plasma membrane components. Binding
studies using membranes and recombinant proteins corresponding to different regions of the L-subunit suggest that a
functional domain previously shown to be involved in the binding of polyamines may also participate to the binding of CK2
to membranes. Modification of membranes by trypsin and phospholipases indicated that the binding process may require
both membrane protein(s) and phospholipids. Interestingly, it was observed that the amount of membrane-bound CK2 in
liver of embryos and new born rats increases dramatically after birth and persists during the postnatal stages of
development. z 1998 Elsevier Science B.V.
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1. Introduction
The protein kinase CK2 (CK2) from most sources
is a tetrameric enzyme composed of two K- (and/or
KP-) subunits and two L-subunits [1,2]. The K- and
KP-subunits contain all of the conserved consensus
motifs of protein kinase family members [3], and
bear the catalytic site [4^7]. The precise functions
of L-subunit are not known, but it does appear to
have a role in regulating the kinase activity of the a
subunit [8^10]. Complementary DNAs encoding the
K-, KP- and L-subunits of CK2 have been isolated
from human and chicken libraries [11^15]. These
studies indicated that the K- and KP-subunits are
closely related proteins that are encoded by distinct
genes. Several studies have demonstrated that cellu-
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lar mammalian CK2 exists as homotetramers (K2L2
or KP2L2) as well as heterotetramers (KKPL2) [16,17].
At present, distinct functions for CK2K and CK2KP
have not been clearly de¢ned. Immunocytochemical
studies of the intracellular localisation of the two
isomeric forms of CK2 have been mostly devoted
to the characterisation of the nuclear and cytoplas-
mic distribution of the kinase, although with some-
what controversial conclusions [18,19]. However,
previous studies have shown that several membrane
receptors, such as the insulin and IGF-II receptors
and the cation independent mannose 6-phosphate
receptor are phosphorylated by CK2 in intact cells
[20^23]. These observations suggest that CK2 may
play a role in the regulation of membrane compo-
nents such as intrinsic receptors. Thus, it may be
suspected that varied subcellular locations of CK2
isoforms may connote di¡erences in biochemical
functions.
Here we report results of our e¡ort aiming at ex-
ploring the functions of CK2 isoforms by localising
these proteins within the cell. We ¢nd that an heter-
otetrameric form of CK2 is tightly associated with
highly puri¢ed rat liver plasma membranes. The as-
sociated protein kinase could be released from the
membrane upon addition of recombinant isolated
L-subunit. Similarly a plasma membrane bound
form of CK2 was isolated from SF9 cells overex-
pressing the CK2 subunits. Using this cell system
we have shown that a speci¢c domain of the L-sub-
unit previously shown to be involved in the binding
of polyamines may target the kinase to the mem-
branes. In addition, membrane treatment by trypsin
or phospholipases, suggests that the reversible bind-
ing of CK2 may require both protein(s) and phos-
pholipids.
A possible involvement of membrane-bound CK2
in postnatal development is suggested by the increase
in CK2 found associated with rat liver plasma mem-
branes after birth in new born rats.
2. Materials and methods
[Q-32P]ATP (3000 Ci/mmol) was from Amersham.
Casein, phosvitin were obtained from Sigma. Phos-
phocellulose was purchased from Whatman. Re-
combinant human basic FGF was provided to us
by J.-J. Feige (INSERM Unite¤ 244, BRCE, Greno-
ble). Antiserum RK is an antiserum generated against
the recombinant K-subunit of CK2 puri¢ed from ba-
culovirus-infected SF9 cells [4]. Antiserum Ab-PKP21
is an anti-peptide antiserum generated against the 21
C-terminal amino acids of the KP-subunit [16]. The
KL-antiserum which was provided by C.V.C. Glover
(University of Georgia, Athens, GA, USA) is a rab-
bit antiserum generated against oligomeric Drosophi-
la CK2 [24]. Bovine CK2 was puri¢ed to homogene-
ity using a previously described method [24].
CK2 activity assay was performed using a syn-
thetic peptide (RRREEETEEE) as substrate, as pre-
viously described [8].
2.1. Immunoblotting
Samples were run on 12% SDS-polyacrylamide
gels and proteins were electrotransferred (1 h, 100
V) onto immobilon P membranes (Millipore). CK2
subunits (K, KP and L) were detected using rabbit
antisera at a 1/500 dilution.
The membranes were then incubated 1 h with
horseradish peroxidase-labelled anti-rabbit IgG anti-
body. The immunocomplexes were visualised using
the enhanced chemiluminescence (ECL) Western
blotting detection system (Amersham).
2.2. Preparation and purity of liver plasma
membranes
Plasma membranes were prepared essentially by
the method of Ray [25], from liver of male albino
Wistar rats (150 g). This preparation was further
puri¢ed by a 5^50% (w/w) continuous sucrose gra-
dient (100 000Ug for 30 min).
Enrichment and purity of ¢nal plasma membrane
preparations have been estimated using speci¢c
marker enzymes, as described by Sarrouilhe et al.
[26]. The purity of the membrane preparation has
been also controlled by electron microscopy which
has not revealed any contaminant.
2.3. Preparation of plasma membrane from infected
SF9 cells
SF9 cells were infected with the recombinant vi-
ruses EV55 DmK and EV55 DmL to express respec-
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tively the K- and L-subunits of CK2, as previously
described [8].
At 3 days postinfection (15U106), cells were har-
vested and homogenised in 20 mM HEPES, pH 7.4,
1.5 mM MgCl2, 1 mM EDTA, 1 mM phenylmethyl
sulphonyl £uoride and 50 mg/ml leupeptin. The cell
lysate was sonicated for 3 min and centrifuged at
15 000Ug for 20 min. The supernatant was then cen-
trifuged at 23 000Ug for 30 min and the pellet was
resuspended in 10 mM Tris HCl, pH 7.4, 1 mM
DTT, and centrifuged again over a cushion of 20%
sucrose in the same bu¡er at 30 000Ug for 1 h. The
pellet was ¢nally resuspended in 10 mM Tris HCl pH
7.4, 1 mM DTT, 2% glycerol (TDG bu¡er) contain-
ing 0.5 M NaCl and the suspension was centrifuged
at 23 000Ug for 30 min. The pellet was resuspended
in TDG bu¡er and frozen by aliquots at 380‡C.
2.4. Partial puri¢cation of CK2 extracted from rat
liver plasma membranes
Highly puri¢ed rat liver plasma membranes (6 mg
protein) were extracted in 0.3 ml TDG bu¡er con-
taining 1.5 M NaCl for 15 min at 4‡C. After centrif-
ugation for 15 min at 15 000Ug, the supernatant was
diluted in 3 ml of TDG bu¡er and applied to a
phosphocellulose column (0.2 ml). The column was
eluted stepwise by 0.5 ml of TDG bu¡er containing
increasing NaCl concentrations.
2.5. Protein kinase CK2 radioactive labelling
Protein kinase CK2 radioactive labelling was car-
ried out as previously described [27].
2.6. Protein expression
Chicken CK2 L-subunit was produced in SF9 cells
and puri¢ed as described [8].
Chicken CK2 L-subunit was also expressed in
E. coli as a fusion protein with the maltose binding
protein (MBP) The sequences coding for the chicken
L-subunit (representing amino acids 1^215) or L-sub-
unit fragment corresponding to amino acids 51^110
were ampli¢ed by PCR from the corresponding
cDNA (kindly provided by Dr. E. Nigg). The PCR
ampli¢cation led to DNA fragments carrying a Bam-
HI site and a HindIII site located respectively at the
5P- and 3P- extremities of the coding sequence. PCR
products were cloned in the pMAL-C2 vector (pro-
tein fusion and puri¢cation system, New England
Biolabs) at the corresponding restriction sites.
The resulting recombinant vectors were used to
transform Escherichia coli strain BL21. The culture
was induced with 0.3 mM isopropyl thiogalactopyr-
anoside (IPTG). The cell pellet was resuspended in
Fig. 1. Isolation of a protein kinase CK2 activity from rat liver
plasma membranes. (A) Highly puri¢ed rat liver plasma mem-
branes (6 mg protein) were extracted by shaking in 0.3 ml of
TDG bu¡er containing 1.5 M NaCl for 15 min at 4‡C. After
centrifugation for 15 min at 15 000Ug, the supernatant was di-
luted in 3 ml of TDG bu¡er and applied to a phosphocellulose
column (2 ml). The column was eluted by a linear NaCl gra-
dient in TDG bu¡er. Protein kinase activity in each fraction
was determined using the speci¢c peptide substrate for CK2.
The assays were carried out as described in Section 2. (B) Frac-
tions from the phosphocellulose column which contained CK2
activity were analysed on a 12% SDS-PAGE and the proteins
were transferred on an immobilon membrane. The membrane
was probed with the RK antibody (anti-K), the Ab-PKP21 anti-
body (anti-KP), and the KL antibody (anti-KL).
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cold lysis bu¡er (10 mM phosphate, 30 mM NaCl,
0.25% Tween 20, 10 mM EDTA, 10 mM EGTA, pH
7.0). After a thermal shock (370 to +20‡C) and a
3U2-min sonication, the lysate was adjusted to
0.5 M NaCl and subjected to centrifugation at
9000Ug for 20 min. The supernatant was then mixed
with amylose resin (New England Biolabs) at 4‡C
during 1 h and the fusion protein was eluted with
10 mM maltose added to column bu¡er (10 mM
phosphate, 0.5 M NaCl, 1 mM azide, 1 mM
EGTA, pH 7.0). The recombinant protein MBP-L
chicken was ¢nally concentrated on a centricon cell
up to 4 mg/ml.
Recombinant mouse p53 was prepared as previ-
ously described [27].
2.7. Embryo collection
Sprague^Dawley rat embryos were surgically re-
moved from anaesthetised mothers (plug day = day
0) placed under an optical microscope. Intact em-
bryos were immediately processed for liver plasma
membrane preparation as described above.
3. Results
3.1. Characterisation of a protein kinase CK2 activity
in rat liver plasma membrane
Highly puri¢ed rat liver plasma membrane were
extracted with a bu¡er containing 1.5 M NaCl and
the extracted proteins were chromatographed on a
phosphocellulose column and eluted with increasing
salt concentrations. Assay of protein kinase activity
in the di¡erent collected fractions using as a sub-
strate a synthetic peptide which has been shown to
be speci¢c for CK2, disclosed the presence of a single
peak of protein kinase activity eluting between 0.6
and 1.5 M NaCl (Fig. 1A). The protein kinase activ-
ity present in these fractions was further character-
ised using di¡erent anti-CK2 antibodies.
A Western blot analysis of the corresponding frac-
tions was performed with anti-CK2 antibodies recog-
nising speci¢cally the K-, KP- and L-subunits. The
results illustrated in Fig. 1B show that the antibodies
recognised polypeptides with molecular weight corre-
sponding to those of the K-, KP- and L-subunits of the
Fig. 2. Salt extraction of protein kinase CK2 from rat liver plasma membranes. Aliquots of plasma membrane (250 Wg) were extracted
for 20 min at 4‡C in 30 Wl TDG bu¡er containing increasing NaCl concentrations. After centrifugation of the extracts, the superna-
tants were used for determination of CK2 activity (a) and the extracted proteins were separated by SDS-PAGE and Western blotted
on an immobilon membrane. The presence of catalytic CK2 subunits was revealed on the membrane using an anti-CK2K antibody.
Membranes were also incubated with 32P-autophosphorylated recombinant CK2 for 30 min at room temperature. Membranes were
washed and extracted in TDG bu¡er containing increasing NaCl concentrations. After centrifugation, the radioactivity present in the
supernatants was counted (b).
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mammalian CK2 [5]. A gel ¢ltration analysis dis-
closed that the protein kinase isolated on phospho-
cellulose was eluting from the column with an appar-
ent molecular weight of 130^150 kDa (not shown).
We therefore conclude that the kinase activity which
is associated with the plasma membrane is an oligo-
meric protein kinase CK2 composed by the associa-
tion of K-, KP- and L-subunits as described for CK2
puri¢ed from either nuclear or cytoplasmic fractions
[28].
3.2. Salt extraction of protein kinase CK2 associated
with plasma membranes
Aliquots of plasma membranes were extracted by
increasing concentrations of NaCl. After centrifuga-
tion the amount of CK2 activity and of immuno-
reactive K- and KP-subunits were determined in the
supernatants. The results illustrated in Fig. 2 show
that the membrane bound kinase could be extracted
by high salt concentrations. A maximum recovery
was achieved for concentrations above 1 M NaCl.
At a concentration of 1.5 M NaCl, almost all the
CK2 subunits present in the membranes were recov-
ered in the supernatant. Plasma membranes were
also incubated with 32P-autophosphorylated re-
Fig. 4. Detection of protein kinase CK2 in plasma membranes from SF9 cells. At 3 days postinfection, SF9 cells (15U106) either un-
infected (control cells) or infected with EV55 DmK+EV55 DmL were used to prepare whole cell extract or plasma membranes. Ali-
quots of whole cell extract (1) or membrane extract (2) were analysed for CK2 activity (A) and for the presence of CK2 K- and
L-subunits by Western blotting detection (B). (C) Aliquots of plasma membranes expressing either the oligomeric CK2 or its isolated
subunits were extracted by increasing NaCl concentrations. CK2 activity was determined in the di¡erent salt extracts of membranes
from cells expressing the oligomeric CK2 (b) or the isolated K-subunit (a). (D) A Western blotting detection was performed on the
salt extracts of membranes from cells expressing the isolated L-subunit.
Fig. 3. CK2 activity in intact membranes and in membrane ex-
tracts. CK2 activity was determined on aliquots of either intact
membranes (8) or after extraction with 2 M NaCl (R) or solu-
bilisation with 1% Triton X-100 (b).
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combinant CK2. After incubation, the membranes
were extracted by increasing NaCl concentrations.
It was observed that the exogenously added CK2
bound to membranes but the kinase was easily ex-
tracted by salt concentrations lower than 0.5 M
NaCl.
3.3. CK2 activity in intact membranes
CK2 activity associated with rat liver plasma
membranes was determined on intact membranes,
and on NaCl or Triton X-100 extracts of the same
membrane samples (Fig. 3). Surprisingly, no kinase
activity was detectable either in intact membranes
nor in Triton X-100 extracts. In contrast, a high
salt extract of membrane exhibited a high CK2 ac-
tivity, suggesting the presence of inhibitory com-
pounds which were separated from the kinase by
salt extraction of membranes.
3.4. Plasma membrane-bound CK2 in SF9 insect cells
overexpressing the CK2 subunits
SF9 cells were co-infected with the baculoviruses
encoding for the K- and L-subunits of CK2. Plasma
membranes and whole cell extract were prepared and
extracted by 1.5 M NaCl. The amount of CK2 sub-
units was quanti¢ed in each extract by CK2 activity
determination and by Western blotting (Fig. 4A,B).
A signi¢cant amount (V8%) of the expressed re-
combinant oligomeric CK2 was recovered in the
plasma membrane fraction. SF9 cells were also sep-
arately infected with bacoloviruses encoding for the
K- and L-CK2 subunits. It was observed that the
extraction of the oligomeric recombinant CK2
present in the plasma membranes required high salt
concentrations (Fig. 4C), a situation already ob-
served for the extraction of CK2 associated with
rat liver plasma membranes (Fig. 2). In contrast,
the isolated K-subunit present in the insect cell mem-
brane was easily recovered in 0.5 M NaCl. Mem-
branes from SF9 cells expressing the L-subunit alone
were extracted in the same conditions. Interestingly,
the salt concentrations which were necessary to ex-
tract the bound L-subunit were similar to those re-
quired to extract the oligomeric CK2 (Fig. 4D).
Taken together, these experiments suggest that
whereas the K-subunit has a low a⁄nity for plasma
membrane, the tight association of the isolated L-
subunit is reminiscent of the binding properties of
the oligomeric form of the kinase.
3.5. Release of plasma membrane-bound CK2 by
recombinant CK2 L-subunit
Aliquots of rat liver plasma membranes were in-
cubated with di¡erent CK2 substrates such as casein,
p53 protein and topoisomerase II. After centrifuga-
tion, the protein kinase activity present in the super-
natants was determined. As shown in Fig. 5, no CK2
activity could be detected in the resulting superna-
tants. However, incubation of membranes with the
isolated CK2 recombinant L-subunit led to the recov-
ery of some CK2 activity in the supernatant. Simi-
larly, incubation of membranes with increasing con-
centrations of L-MBP fusion protein expressed in E.
coli could release CK2 activity. More than 60% of
the amount of CK2 extracted by 1.5 M NaCl was
released upon incubation of membranes with 24 WM
Fig. 5. Release of protein kinase CK2 from rat liver plasma
membranes upon incubation with recombinant CK2 L-subunit.
Aliquots of plasma membranes were incubated for 30 min at
4‡C with the following additions: 1.5 M NaCl, 30 WM casein,
1 WM p53, 1 WM topoisomerase II, 1 WM recombinant L-sub-
unit expressed in SF9 cells, 10 WM MBP, or increasing concen-
tration of L-MBP fusion protein expressed in E. coli. After cen-
trifugation of the extracts, aliquots of the di¡erent supernatants
were used for CK2 activity determination. Membrane pellets
were analysed for the presence of the L-MBP fusion protein by
Western blotting. The membrane was probed with anti-MBP
antibody (inset). This experiment is representative of three sepa-
rate experiments.
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of the L-MBP fusion protein. Under these experi-
mental conditions, the L-MBP fusion protein exhib-
ited a saturable binding to plasma membranes (Fig.
5, inset) At the same concentrations MBP alone had
no e¡ect. Thus these experiments provide evidence
that the regulatory subunit of the membrane-bound
form of CK2 is the speci¢c interacting subunit medi-
ating the attachment of CK2 to plasma membrane
components.
To delineate further the region of the L-subunit
which is involved in this interaction, aliquots of rat
liver plasma membranes were incubated with syn-
thetic peptides or fusion proteins corresponding to
di¡erent regions of the CK2 L-subunit (Fig. 6A).
The amino terminal domain (GST1ÿ55 or pep-
tide1ÿ77) was without e¡ect on the membrane-bound
CK2. However fragments of the L-subunit which
contain the region between residues 51 and 110
(GST1ÿ150, GST51ÿ150, MBP51ÿ110) could release
CK2 activity. More than 70% of the amount of
CK2 extracted by the L-MBP fusion protein was
released upon incubation of membranes with 20 WM
of MBP51ÿ110. Under the same conditions,
peptide155ÿ215 which corresponds to the C-terminal
domain of the L-subunit was without e¡ect.
Altogether, this experiment suggests that the asso-
ciation of CK2 with plasma membrane components
is mediated by a speci¢c L-subunit domain localised
between residues 51 and 110. It has been shown pre-
viously that this region represents a regulatory do-
main which binds polybasic compounds like poly-
amines. Indeed it was observed that when plasma
membranes were incubated with increasing concen-
trations of spermine, this polyamine was competing
against CK2 binding, causing the release of the kin-
ase from the membrane (Fig. 6B).
3.6. Nature of the CK2 binding sites in plasma
membranes
To better elucidate the nature of the CK2 receptor
site(s), plasma membranes from SF9 cells expressing
the CK2 subunits were either extracted by 1 M NaCl
or incubated in the presence of Trypsin or phospho-
lipase D. At the end of the incubation, membranes
were centrifuged and the presence of CK2 in the
supernatants was quanti¢ed (Fig. 7A). It was ob-
served that both NaCl extraction or trypsin treat-
ment resulted in a similar release of CK2 activity
which correlated with the presence of K- and L-sub-
units in the supernatants (Fig. 7A, inset). Treatment
of membranes with phospholipase D also led to a
substantial release of CK2 activity. Quantitation of
the data showed that treatment of membranes with
Fig. 6. Release of protein kinase CK2 from rat liver plasma
membranes upon incubation with a speci¢c CK2 L-subunit do-
main. (A) Aliquots of plasma membranes were incubated for 30
min at 4‡C in the presence of 20 WM of fusion proteins con-
taining di¡erent L-subunit regions or synthetic peptide corre-
sponding to the L-subunit sequences 1^77 and 155^215. After
centrifugation of the extracts, aliquots of the di¡erent superna-
tants were used for CK2 activity determination. (B) Aliquots of
plasma membranes were incubated for 30 min at 4‡C with in-
creasing concentrations of spermine or with 1 M NaCl. After
centrifugation, aliquots of the di¡erent supernatants were as-
sayed for CK2 activity. This experiment is representative of two
separate experiments.
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either NaCl or trypsin promoted the release of al-
most 100% of the kinase subunits present in the
membranes. Under the same conditions, phospholip-
ase D released 30% of the membrane bound CK2.
Phospholipase A2, C and phosphatidylinositol spe-
ci¢c phospholipase C were without e¡ect (not
shown). A gel ¢ltration analysis was carried out on
CK2 fractions released by either NaCl, trypsin or
phospholipase D treatments. The results depicted in
Fig. 7B showed that for each condition, the released
CK2 activity, eluted from the column at a position
corresponding to the whole heterotetrameric holoen-
zyme.
Fig. 8. Release of CK2 substrates from plasma membranes. (A)
Aliquots of plasma membranes from SF9 cells overexpressing
CK2 subunits were incubated for 20 min at 20‡C in the pres-
ence of 1 M NaCl (lanes 1 and 2), 50 Wg/ml Trypsin (lanes 3
and 4), or 9 units of PLD (lanes 5 and 6). Membranes from
non-infected SF9 cells were extracted by 1 M NaCl (lanes 7
and 8). After centrifugation of the extracts, aliquots of the
supernatants were incubated for 10 min at 30‡C with 50 WM
[Q-32P]ATP+10 mM MgCl2 in the absence or presence of hepa-
rin (lanes 1 and 6) or in the absence or presence of 0.1 Wg re-
combinant CK2 (lanes 7 and 8). Proteins were separated by
SDS-PAGE and the dried gel was exposed for autoradiography.
(B) Plasma membranes from SF9 cells overexpressing the CK2
subunits were extracted with 1 M NaCl. After centrifugation of
the extract, the supernatant was incubated for 10 min at 30‡C
with 50 WM [Q-32P]ATP+10 mM MgCl2. The sample was then
loaded on an amylose column containing the MBP-L fusion
protein. The column was eluted stepwise by increasing NaCl
concentrations. The phosphorylated proteins present in the dif-
ferent fractions were separated by SDS-PAGE and visualised
by autoradiography.
Fig. 7. Nature of the CK2 binding sites in plasma membranes.
(A) Aliquots of membranes from SF9 cells overexpressing CK2
subunits were incubated for 20 min at 30‡C with the following
additions: (1) TDG bu¡er; (2) 1 M NaCl; (3) 50 Wg/ml trypsin;
and (4) 9 units of Phospholipase D. After centrifugation of the
extracts, aliquots of the di¡erent supernatants were used for
CK2 activity determination. Inset: aliquots of the membrane
pellets and of the supernatants were analysed by Western blot-
ting and the membrane was probed with anti-CK2 subunit anti-
bodies. (B) Aliquots of the supernatants were also loaded on a
ACA 34 Ultrogel column (0.7U0.9 cm) equilibrated in TDG
bu¡er containing 1 M NaCl. Aliquots of the collected fractions
(0.15 ml) were assayed for CK2 activity. NaCl (a), trypsin (b),
phospholipase D (U). The exclusion volume and the position
of the elution of goat IgG (MW 150 kDa) are indicated.
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3.7. Presence of CK2 substrates in plasma membranes
We checked whether the kinase was released to-
gether with membrane proteins which might be
CK2 substrates. It was observed that several proteins
with molecular weight ranging from 20 to 80 kDa
were extracted from the membrane by NaCl or by
incubation with trypsin or phospholipase D. These
proteins were phosphorylated by the released CK2
because their phosphorylation was strongly inhibited
by heparin (Fig. 8A). The same proteins were also
extracted by phospholipase D treatment of mem-
branes of non infected SF9 cells and were also phos-
phorylated by exogenously added CK2 (Fig. 8A,
lanes 7 and 8).
A high salt extract of membranes from SF9 cells
overexpressing the CK2 subunits was incubated in
the presence of [Q-32P]ATP/MgCl2 and then loaded
on a column of L-MBP fusion protein immobilised
on amylose resin. As shown in Fig. 8B, most of the
CK2 substrates were bound to the L-MBP fusion
protein and were eluted in the presence of 0.4^0.6
M NaCl. As a control, these CK2 substrates were
not retained on a column of immobilised MBP
(data not shown).
3.8. Increased CK2 association with plasma
membranes in postnatal rat liver
The membrane-bound CK2 was examined during
the liver development of embryonic and postnatal
rats. The presence of CK2 was probed in puri¢ed
plasma membrane by CK2 activity determination
and by Western blotting (Fig. 9) Membrane-bound
CK2 level was low in prenatal liver (embryonic day
16.5 to birth). Then, a striking increase in CK2 was
observed during the ¢rst week after birth and high
level of membrane-bound CK2 persisted during sev-
eral weeks. A Western blot analysis disclosed that the
kinase contained a stoichiometric amount of K- and
KP-subunits.
4. Discussion
Protein kinase CK2 itself, as well as its potential
speci¢c intracellular substrates are found in the dif-
ferent compartments of the cell [2], indicating a local-
isation-immanent speci¢cation of the enzyme. Immu-
nocytochemical studies have shown that in most cell
types, CK2 is detected both in the cytoplasm and the
nucleus [18,19,29]. Detection of CK2 activity in plas-
ma membrane preparations has been previously re-
ported [32^34].
The presence of an ecto-protein kinase associated
with plasma membrane from HeLa cells [30,31] and
human neutrophils [33] has been described by several
groups. A casein kinase 2-like enzyme was also iden-
ti¢ed in caveolin-rich membranes [34]. Similarly, the
presence of casein kinase I associated with rat liver
plasma membrane has already been observed [35].
Here we report the presence of an oligomeric form
of CK2 tightly associated with highly puri¢ed rat
liver plasma membrane preparations.
Fig. 9. Membrane-bound CK2 during embryonic and postnatal
rat liver development. Plasma membranes were prepared from
liver of embryonic (E17^E20) and postnatal rats. The di¡erent
samples were normalised for their protein content and CK2 ac-
tivity was determined in 2 M NaCl extract of membranes (b).
The liver weight at each stages was also determined (F). Inset:
sample of the extracted proteins were separated by SDS-PAGE
and Western blotted on an immobilon membrane. The presence
of CK2 subunits was revealed on the membrane using anti-
CK2 antibodies.
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The protein kinase activity which eluted at 0.8^0.9
M NaCl on phosphocellulose, phosphorylated inten-
sively a peptide substrate established as being speci¢c
for CK2. Using speci¢c antibodies recognising the
di¡erent subunits of CK2, we found that this protein
kinase contained the two catalytic K- and KP-subunits
and the regulatory L-subunit characteristic of CK2
puri¢ed from di¡erent sources. The apparent molec-
ular weight (w140 kDa) suggests that the protein
kinase is oligomeric, thus the enzyme has all the hall-
marks of authentic CK2.
Several CK2 isoforms containing two di¡erent cat-
alytic subunits have been described in di¡erent tis-
sues [16] and rat liver homogenates contained several
forms of CK2 activity that could be separated by ion
exchange chromatography [36]. Interestingly, CK2
activity extracted from rat liver plasma membrane
was found to eluate as a single peak on di¡erent
chromatographic steps. A Western blot analysis
showed that this puri¢ed CK2 contained both K-
and KP-subunits. The amount of CK2 associated
with puri¢ed plasma membrane was calculated to
represent 2.4 and 8% of the CK2 activity present in
rat liver and in CK2-expressing SF9 cells, respec-
tively.
The presence of CK2 associated with plasma mem-
branes is not restricted to rat liver since we have also
detected this protein kinase in plasma membranes
derived from A431 cells.
Until now, the nature of the association of CK2
with membranes has not been examined in detail. We
do not know the topographical orientation of the
protein kinase within the plasma membrane. There-
fore, we cannot assess if this membrane bound form
of CK2 is an ectoprotein kinase [30,31] or a periph-
eral membrane protein exposing its catalytic domain
toward the cytoplasm. However the casein kinase 2-
like enzyme associated with caveolin-rich membrane
domains was shown to phosphorylate the cytoplas-
mic domain of caveolin [34], suggesting that the kin-
ase is oriented toward the cytoplasm. Interestingly,
the enzyme associated with rat liver plasma mem-
branes was tightly bound to membranes and its re-
lease occurred upon extraction with high ionic
strength (s 1 M NaCl). In contrast, exogenous
CK2 was able to bind to membrane, but was easily
extracted by low salt concentrations. Similarly it has
been observed that most of the nuclear bound CK2
is readily extracted by 0.5 M NaCl (unpublished re-
sults). It is not known if the attachment of CK2 to
membranes requires a speci¢c covalent modi¢cation,
but our observation that the kinase is extracted by
high salt concentrations suggests that electrostatic
interactions between protein domains and membrane
lipids or protein^protein interactions may contribute
to binding. Using the SF9 cell system, we found that
the extractibility of the isolated L-subunit recovered
from the plasma membrane fraction was identical to
the one observed for the native liver CK2 and the
recombinant oligomeric CK2 in SF9 cells. From
these experiments, it is tempting to speculate that
the L-subunit is the targeting subunit which is re-
sponsible for the tight anchoring of the oligomeric
enzyme in the plasma membrane. This notion is
strengthened by the competition experiments de-
scribed in Fig. 5, showing that whereas several
CK2 substrates could not release the membrane-
bound kinase, the recombinant L-subunit bound to
membranes and could e⁄ciently displace the kinase
from its binding sites. These observations imply that
the catalytic CK2 subunits are not involved in this
interaction, but rather provide evidence for a major
role for the regulatory subunit in mediating this
membrane attachment.
As far as the exact mechanism of the interaction of
CK2 with plasma membrane is concerned, the mo-
lecular mechanism of this association is not known.
The fact that both baculovirus and E. coli-expressed
L-subunits disclosed the same potency in displacing
the membrane-bound CK2, supports the notion that
no covalent modi¢cation of this targeting subunit is
required for the interaction.
To delineate the region of the L-subunit which is
involved in this interaction, di¡erent fragments of
this subunit were tested in competition experiments.
A fusion protein containing the region between res-
idues 51 and 110 was found to release speci¢cally the
membrane-bound CK2. This observation could be
interpreted as an indication that this region is indeed
a CK2-membrane targeting domain.
It has been recently observed that this region rep-
resents a regulatory domain which binds polybasic
compounds such as polyamines and mediates the
polyamine-stimulation of CK2 [37]. Interestingly,
the membrane-bound CK2 could be released by
high spermine concentrations. The fact that this do-
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main can easily displace the membrane-bound CK2
indicates that the kinase may interact with polyca-
tionic membrane components. We have observed
that CK2 activity could not be detected in intact
membranes unless a high salt extraction was per-
formed. Similarly, Triton X-100 extracts from mem-
brane did not exhibit a detectable CK2 activity
although a Western blot analysis indicated that the
kinase was indeed solubilised in the presence of
detergent. Thus, plasma membranes may contain
CK2-inhibitory components which, like CK2, are
extractable in the presence of Triton X-100. The
same inhibitory components are apparently not re-
leased after salt extraction of plasma membranes.
Altogether, these observations lend support to the
notion that plasma membranes harbor a cryptic
form of CK2 which is under a tight inhibitory con-
trol.
To elucidate the nature of the CK2 receptor site(s),
membranes were incubated in the presence of trypsin
or phospholipases. It was observed that both trypsin
and phospholipase D treatments are able to release
the whole heterotetrameric holoenzyme from the
membranes. This observation may indicate that
membrane proteins and/or membrane phospholipids
are involved in the binding of CK2 to membranes.
However, it should be pointed out that the enzymatic
extractions of the kinase was carried out only to gain
evidence for di¡erent binding sites for the association
of the enzyme and not to de¢ne the biochemical
composition of the CK2 binding sites. The results
illustrated in Fig. 7A only suggest that both mem-
brane proteins and phospholipids are required at, or
near, speci¢c binding sites to mediate this type of
membrane association.
The fact that both enzymatic treatments or salt
extraction of membranes released a limited number
of membrane proteins which are CK2 substrates,
raises the possibility that some of these proteins
may represent potential CK2 anchoring proteins
present in the plasma membranes. This notion is
supported by the observation illustrated in Fig. 8B
showing that these CK2 substrates are interacting
with recombinant CK2-L-subunit.
The membrane bound form of CK2 observed in
the liver of adult rat is undetectable in the liver of rat
embryos. Interestingly, a striking increase in the level
of the kinase associated with plasma membranes was
observed after birth and the presence of the enzyme
in this compartment persists during the postnatal
stages of development. Based on these observations,
we conclude that the membrane localisation of CK2
is developmentally regulated. In this context, it has
been previously observed that CK2 activity is ele-
vated in 12-day mouse embryos as compared to oth-
er embryonic stages and 6-day-old mice [38]. How-
ever, this study was performed in low salt extract of
whole mouse embryos and the presence of mem-
brane-bound CK2 was not addressed. More recently,
it was observed that foetal hepatic CK2 was largely
localised to the nucleus until birth. In contrast, CK2
was absent from adult nuclear extract [39]. This
study, together with our own, demonstrate that a
complex intracellular redistribution of CK2 takes
place in late foetal and postnatal rat liver develop-
ment.
It is not known at this time what functions this
membrane bound form of CK2 might serve. Com-
partmentalisation of protein kinases resulting from
their binding to speci¢c anchoring proteins is a well
documented observation [40]. In this context, the
association of CK2 to plasma membranes would
place the kinase close to certain substrates but also
cluster it with enzymes that may regulate its activ-
ity.
The challenge now is to pinpoint which important
cellular phosphorylation events are regulated by this
membrane-bound form of the enzyme.
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